National Bank of Canada
ENVB icon

National Bank of Canada’s Enveric Biosciences ENVB Stock Holding History

National Bank of Canada’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
1
– – ﹤0.01% 3114
2026
Q1 		$2 Hold
1
– – ﹤0.01% 2926
2025
Q4 		$4 Buy
+1
New +$7 ﹤0.01% 2856
2025
Q3 		– Hold
0
– – – 2823
2025
Q2 		– Hold
0
– – – 2955
2025
Q1 		– Hold
0
– – – 2806
2024
Q4 		– Hold
0
– – – 2844
2024
Q3 		– Hold
0
– – – 2612
2024
Q2 		– Hold
0
– – – 2653
2024
Q1 		– Hold
0
– – – 2682
2023
Q4 		– Hold
0
– – – 2662
2023
Q3 		– Hold
0
– – – 2712
2023
Q2 		– Hold
0
– – – 2663

Other funds holding ENVB

SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

National Bank of Canada's ENVB Position: Q2 2026 in Review

National Bank of Canada held its Enveric Biosciences (ENVB) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #3114.

National Bank of Canada first reported a position in ENVB in Q4 2025 and has held it in 3 quarters since. The position peaked at $4 in Q4 2025. 24 funds tracked by Wall St. Rank hold ENVB as of Q2 2026.

  • National Bank of Canada held 1 share of Enveric Biosciences worth $1 as of Q2 2026.
  • National Bank of Canada left its Enveric Biosciences share count unchanged in Q2 2026.
  • Enveric Biosciences made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #3114 holding.
  • National Bank of Canada first reported a position in Enveric Biosciences in Q4 2025 and has held it in 3 quarters since.
  • National Bank of Canada's Enveric Biosciences position peaked at $4 in Q4 2025.
  • 24 funds tracked by Wall St. Rank held Enveric Biosciences as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.